Gordon, Anthony C.; Mouncey, Paul R.; Al-Beidh, Farah; Rowan, Kathryn M.; Nichol, Alistair D.; Arabi, Yaseen M.; Annane, Djillali; Beane, Abi; van Bentum-Puijk, Wilma; Berry, Lindsay R.; Bhimani, Zahra; Bonten, Marc J.M.; Bradbury, Charlotte A.; Brunkhorst, Frank M.; Buzgau, Adrian; Cheng, Allen C.; Detry, Michelle A.; Duffy, Eamon J.; Estcourt, Lise J.; Fitzgerald, Mark; Goossens, Herman; Haniffa, Rashan; Higgins, Alisa M.; Hills, Thomas E.; Horvat, Christopher M.; Lamontagne, Francois; Lawler, Patrick R.; Leavis, Helen L.; Linstrum, Kelsey M.; Litton, Edward; Lorenzi, Elizabeth; Marshall, John C.; Mayr, Florian B.; McAuley, Danny; McGlothlin, Anna; McGuinness, Shay P; McVerry, Bryan J.; Montgomery, Stephanie K.; Morpeth, Susan C.; Murthy, Srinivas; Orr, Katrina; Parke, Rachael L.; Parker, Jane C.; Patanwala, Asad E.; Pettilä, Ville; Rademaker, Emma; Santos, Marlene S.; Saunders, Christina T.; Seymour, Christopher W.; Shankar-Hari, Manu; Sligl, Wendy I.; Turgeon, Alexis F.; Turner, Anne M.; van de Veerdonk, Frank L.; Zarychanski, Ryan; Green, Cameron; Lewis, Roger J.; Angus, Derek C.; McArthur, Colin J.; Berry, Scott; Webb, Steve A.; Derde, Lennie P.G.
Published 2021
Abstract Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and sarilumab in an ongoing ...